FDA pharmacologic class
Proteasome Inhibitor
3 medicines are in FDA's class of proteasome inhibitors: bortezomib (Velcade), carfilzomib (Kyprolis) and ixazomib (Ninlaro). 1 of the 3 are listed from generic labelers (FDA NDC Directory, October 8, 2026).
Which medicines are proteasome inhibitor?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Bortezomib | Velcade, Boruzu | 22 labelers | n/a | No | No current entry | 3 |
| Carfilzomib | Kyprolis | none listed | n/a | No | No current entry | 2 |
| Ixazomib | Ninlaro | none listed | n/a | No | No current entry | 0 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)